EU Report Puts Generics And Biosimilars In The Frame
EU Also Needs More Teamwork On Drug Pricing & Access
EU member states are being urged by the European Commission to cooperate more closely on pricing and reimbursement, managed access deals and policies to promote generics and biosimilars.
